“Let’s give high marks to the FDA for reaching out to begin a conversation with the mobile health industry and consumers. There is a lot to discuss, as this Q&A attests. Regulatory authorities clearly need to play an important role in defining the boundaries of what is inside and outside their domains, and mobile health and wellness experts need to advocate for definitions that maintain innovation and the rapid growth of this field for consumers and patients.”
Article
David O’Reilly, Intelligent Medicine Blog, 23 February 2009
